论文部分内容阅读
目的:观察枸橼酸咖啡因注射液治疗早产新生儿原发性呼吸暂停的治疗疗效。方法:通过2013年9月-2014年9月我院治疗的50例原发性呼吸暂停的早产儿进行分析研究。通过随机数表法,将患儿随机均分为观察组和对照组。观察组患儿采用枸橼酸咖啡因注射液进行治疗,对照组患儿则通过氨茶碱治疗。对两组患者治疗之后的临床呼吸暂停情况进行统计分析。结果:对所有患儿治疗之后的临床呼吸暂停情况统计表明:观察组患儿治疗1天后、治疗2天后和治疗3天后的呼吸暂停次数分别为(6.845±2.013次)、(4.275±1.233次)和(1.535±0.401次)均显著低于对照组患儿的治疗后的呼吸暂停次数,差异比较均具有统计学意义(P<0.05)。结论:枸橼酸咖啡因注射液可以有效的治疗早产新生儿原发性呼吸暂停,明显减少患儿的呼吸暂停次数,临床治疗建议广泛采纳。
Objective: To observe the curative effect of citrate caffeine injection in the treatment of premature neonates with primary apnea. Methods: Fifty patients with primary apnea in our hospital from September 2013 to September 2014 were analyzed. By random number table method, the children were randomly divided into observation group and control group. Children in the observation group were treated with citrulline citrate injection while those in the control group were treated with aminophylline. Statistical analysis of clinical apnea status after treatment was performed in both groups. Results: The statistics of clinical apnea after treatment in all children showed that the number of apnea cases in the observation group after 1 day of treatment, 2 days after treatment and 3 days after treatment were 6.845 ± 2.013 times and 4.275 ± 1.233 times, respectively And (1.535 ± 0.401) were significantly lower than those in the control group after treatment of apnea, the difference was statistically significant (P <0.05). Conclusion: Citrate caffeine injection can effectively treat primary neonatal premature neonatal apnea, significantly reduce the number of children with apnea, clinical treatment is widely recommended.